home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Optimizing Patient Adherence in Clinical Trials: The Science of Risk Identification and Personalized Digital Interventions

 
  April 01, 2025  
     
 
Xtalks, Online
2025-05-09


The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly, treatment adherence and engagement in study protocols are critical for clinical trial success.

Every research participant who discontinues study drug, fails to provide clinical data, or drops out of a study, reduces its statistical power, and may bias the results, impacting credibility.  In this webinar, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting.

The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research.

Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful, effective approaches should apply the findings from behavioral science, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial, a valid assessment of patients’ beliefs, attitudes and behaviors allows for rational and personalized interventions, including solutions using digital tools.

Register for this webinar today to explore how evidence-based behavioral frameworks, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials.

Keywords: Clinical Trials, Drug Development, Clinical Research, Patient-Centricity, CRO, Patient Recruitment, Patient Engagement, Risk Management, Clinical Trial Design, Clinical Study Design, Patient Diversity
 
 
Organized by: Xtalks
Invited Speakers: Dr. Nicholas Alp, MD, PhD, FACC, Chief Medical Officer, Clinical ink
Kevin Dolgin, MRes, MBA, Co-founder, Observia
Dr. John D. Piette, MS, PhD, Professor of Global Public Health, University of Michigan
 
Deadline for Abstracts: 2025-05-09
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2025 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.